- Home
- / PRA Health Sciences
- / Financials
PRA Health SciencesHeader placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Financial statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 2.9B | 3.1B | 3.2B |
| Revenue growth, % | 27.0% | 6.8% | 3.8% |
| Cost of goods sold | 2.1B | 2.2B | 2.3B |
| Gross profit | 1.1B | 876.6M | 868.6M |
| Gross profit margin, % | 37.0% | 28.6% | 27.3% |
| General and administrative expense | 371.8M | 394.9M | 453.0M |
| Operating expense total | 484.0M | 509.8M | 584.7M |
| Depreciation and amortization | 112.2M | 114.9M | 131.6M |
| EBITDA | 393.6M | 478.8M | 459.7M |
| EBITDA margin, % | 13.7% | 15.6% | 14.4% |
| EBIT | 281.3M | 363.9M | 328.1M |
| EBIT margin, % | 9.8% | 11.9% | 10.3% |
| Investment income | 143.0K | ||
| Interest expense | 57.4M | 52.0M | 43.1M |
| Pre tax profit | 221.5M | 305.9M | 259.0M |
| Income tax expense | 67.2M | 62.8M | 62.0M |
| Net Income | 154.5M | 243.1M | 197.0M |
| EPS | 2.3 | 3.7 | 3.0 |